arrow
K

Kristýna Němejcová

General University Hospital Prague
H指数:25
被引数:4,066

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immunohistochemical expression of p53 is a helpful surrogate marker in the differential diagnosis of primary ovarian mucinous tumors: a large study of 181 cases of mucinous borderline tumor and carcinoma

p53免疫组化表达是原发性卵巢黏液性肿瘤鉴别诊断中有用的替代标志物:一项包含181例黏液性交界性肿瘤和癌的大样本研究

2026-09-230
PRE
Quality of life outcomes after sentinel lymph node biopsy in patients with early-stage cervical cancer: Results from the prospective multicentre SENTIX study

早期宫颈癌患者行前哨淋巴结活检术后的生活质量结局:来自前瞻性多中心SENTIX研究的结果

2026-08-100
PRE
Sentinel lymph node mapping in early-stage cervical cancer: Results from the SENTIX prospective multicenter study

早期宫颈癌的哨兵淋巴结显像:SENTIX前瞻性多中心研究的结果

2025-10-090
PRE
Sentinel lymph node biopsy without systematic pelvic lymphadenectomy in females with early-stage cervical cancer: final outcome of the SENTIX prospective, single-arm, noninferiority, international trial

早期宫颈癌女性患者前哨淋巴结活检而不进行系统性盆腔淋巴结清扫术: SENTIX前瞻性单臂非劣效性国际试验的最终结果

2025-07-040
PRE
TRPS1 expression in 451 tubo-ovarian tumours: a potential prognostic marker for high-grade serous carcinoma

TRPS1在451例输卵管-卵巢肿瘤中的表达:高分级浆液性癌的潜在预后标志物

2025-05-260
PRE
Decoding the Molecular Landscape of 262 Uterine Sarcomas: RNA-Seq Clustering of Endometrial Stromal Sarcomas, Uterine Tumors Resembling Ovarian Sex Cord Tumors, and Undifferentiated Uterine Sarcomas With Prognostic Insights

解码262例子宫肉瘤的分子景观:具有预后见解的子宫内膜间质肉瘤、卵巢性索样子宫肿瘤和未分化子宫肉瘤的RNA-Seq聚类分析

2025-05-240
PRE
Preoperative tumour size assessment in patients with early-stage cervical cancer: Final results of the SENTIX study

早期宫颈癌患者术前肿瘤大小评估:SENTIX研究的最终结果

2025-05-010
PRE
The Rare Gynecologic Sarcoma Study: Molecular and Clinicopathologic Results of A Project on 379 Uterine Sarcomas

罕见的妇科肉瘤研究: 379子宫肉瘤项目的分子和临床病理结果

2025-05-010
PRE
Immunohistochemical analysis of 147 cases of low-grade endometrial stromal sarcoma: refining the immunohistochemical profile of LG-ESS on a large, molecularly confirmed series
2025-01-210
OAAI
Uterine sarcoma with KAT6B/A::KANSL1 fusion: a molecular and clinicopathological study on 9 cases

子宫肉瘤合并KAT6B/A::KANSL1融合: 9例分子和临床病理研究

2024-12-042
OAAI